Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes |
| |
| Institution: | 1. Pennsylvania State University College of Medicine, Hershey, Pennsylvania;2. Department of Public Health Sciences & Center for Applied Studies in Health Economics, Pennsylvania State University College of Medicine, Hershey, Pennsylvania;3. Division of General Internal Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania;1. Children''s Minnesota, Minneapolis, Minnesota;2. Ann & Robert H. Lurie Children''s Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois;3. Children''s Mercy Kansas City, Missouri;1. Clinical Research Center, Beijing Children''s Hospital, Capital Medical University, National Center for Children''s Health, Beijing, China;2. Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Capital Medical University, Beijing, China;3. Center for Clinical Epidemiology and Evidence-based Medicine, Beijing Children''s Hospital, Capital Medical University, National Center for Children''s Health, Beijing, China;4. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China;5. Department of Cardiology, Peking University First Hospital, Beijing, China;1. Department of Medicine, Division of General Internal Medicine & Health Services Research, University of California, Los Angeles, California;2. Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California;3. Center for Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California;4. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California;1. GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom;2. GSK, Philadelphia, PA, USA;3. GSK, Research Triangle Park, NC, USA |
| |
| Abstract: | The cost of insulin has increased exponentially since its discovery in the 1920s, but the degree to which this financial burden has been transferred to patients is unknown. The present study is a retrospective analysis using claims data for privately insured patients with type 1 diabetes from 2005 to 2017. We quantify the mean annual out-of-pocket costs for insulin and diabetes-related supplies during the study period. It is imperative for health care professionals to be aware of this cost, and we hope that these findings serve as a call for legislation to cap the rising price of insulin. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
